- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02449447
Blended Depression Therapy: Cognitive Behaviour Therapy Face-to-face and Via Internet (E-compared)
September 19, 2017 updated by: Gerhard Andersson, Linkoeping University
European Comparative Effectiveness Research on Internet-based Depression in Sweden (E-compared) Treatment). A Randomized Controlled Trial Comparing Blended Internet and Face-to-face CBT Against Treatment as Usual
To asses the clinical effectiveness of blended cognitive behavior therapy (CBT): face-to-face and internet-based treatment for adults with Major Depressive Disorder (MDD) in primary care compared to treatment as usual.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study is part of a EU-project.
Participants are recruited via regular routes from primary care settings.
Following the Mini International Neuropsychiatric Interview (M.I.N.I.) participants will be randomly allocated to either blended treatment for 10 sessions/weeks or to treatment as usual.
We will include 150 participants in total.
Study Type
Interventional
Enrollment (Anticipated)
150
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Östergötland
-
Linköping, Östergötland, Sweden, 58183
- Department of Behavioral Sciences and Learning, Linköping University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- depressive symptoms according to DSM-IV
- have access to a computer with internet connection
- have good knowledge of the Swedish language
Exclusion Criteria:
- recent (during last 6 weeks) change in psychiatric medication
- presently in any other psychological treatment
- severe depression
- suicidal ideation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Blended treatment
10 weeks of four face-to-face Cognitive behavioral therapy sessions and internet-based CBT as a complement and support to the four sessions.
|
CBT based on behavioral activation and cognitive therapy techniques including homework
|
|
Active Comparator: Treatment as usual
Usual course of antidepressants and management in primary care (e.g medication and supportive counselling).
|
Treatment as usual in primary care including antidepressants and counselling
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quick Inventory of Depressive Symptomatology Self-Report (QIDS
Time Frame: Change from baseline in symptoms of depression. Time Frame: 0, 3, 6 and 12 months
|
Symptoms of depression measured by the QIDS.
The QIDS is a questionnaire that screens for depressive symptoms and assesses depression severity.
|
Change from baseline in symptoms of depression. Time Frame: 0, 3, 6 and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
EuroQol-5D (EQ-5D-5L)
Time Frame: Time Frame: 0, 3, 6 and 12 months
|
Quality of life will be assessed with the EQ-5D-5L (EuroQol).
The EQ-5D-5L is a self-report questionnaire which measures health related quality of life.
|
Time Frame: 0, 3, 6 and 12 months
|
|
Client Satisfaction Questionnaire (CSQ-8)
Time Frame: Time Frame: 3 months (post treatment)
|
Patient's satisfaction with the treatment is assessed with Client Satisfaction Questionnaire (CSQ-8)
|
Time Frame: 3 months (post treatment)
|
|
Credibility and Expectancy Questionnaire (CEQ)
Time Frame: Time Frame: 3 months (post treatment)
|
Patients' expectancy of treatment will be assessed with the credibility and expectancy questionnaire (CEQ)
|
Time Frame: 3 months (post treatment)
|
|
System Usability Scale (SUS)
Time Frame: Time Frame: 3 months (post treatment)
|
Satisfaction with the internet platform will be evaluated with the system usability scale (SUS)
|
Time Frame: 3 months (post treatment)
|
|
Patient Health Questionnaire (PHQ-9)
Time Frame: Time Frame: 0, 3, 6 and 12 months
|
The PHQ-9 is a nine-item mood module that can be used to screen and to diagnose patients with depressive disorders.
|
Time Frame: 0, 3, 6 and 12 months
|
|
Working Alliance Inventory (WAI-SF)
Time Frame: Time Frame: 0 months ( three weeks after started treatment)
|
The therapeutic alliance between therapists and patient will be assessed with the short version of the Working Alliance Inventory (WAI-SF).
|
Time Frame: 0 months ( three weeks after started treatment)
|
|
Trimbos and iMTA questionnaire on Costs associated with Psychiatric illness (TIC-P)
Time Frame: Time Frame: 0, 3, 6 and 12 months
|
Health service uptake and production loss due to illness will be measured with the Trimbos and iMTA Questionnaires on Costs Associated with Psychiatric Illness (TiC-P)
|
Time Frame: 0, 3, 6 and 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Heleen Riper, PhD, VU University of Amsterdam
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- van Genugten CR, Schuurmans J, Hoogendoorn AW, Araya R, Andersson G, Banos R, Botella C, Cerga Pashoja A, Cieslak R, Ebert DD, Garcia-Palacios A, Hazo JB, Herrero R, Holtzmann J, Kemmeren L, Kleiboer A, Krieger T, Smoktunowicz E, Titzler I, Topooco N, Urech A, Smit JH, Riper H. Examining the Theoretical Framework of Behavioral Activation for Major Depressive Disorder: Smartphone-Based Ecological Momentary Assessment Study. JMIR Ment Health. 2021 Dec 6;8(12):e32007. doi: 10.2196/32007.
- Kleiboer A, Smit J, Bosmans J, Ruwaard J, Andersson G, Topooco N, Berger T, Krieger T, Botella C, Banos R, Chevreul K, Araya R, Cerga-Pashoja A, Cieslak R, Rogala A, Vis C, Draisma S, van Schaik A, Kemmeren L, Ebert D, Berking M, Funk B, Cuijpers P, Riper H. European COMPARative Effectiveness research on blended Depression treatment versus treatment-as-usual (E-COMPARED): study protocol for a randomized controlled, non-inferiority trial in eight European countries. Trials. 2016 Aug 3;17(1):387. doi: 10.1186/s13063-016-1511-1.
- Vernmark K, Hesser H, Topooco N, Berger T, Riper H, Luuk L, Backlund L, Carlbring P, Andersson G. Working alliance as a predictor of change in depression during blended cognitive behaviour therapy. Cogn Behav Ther. 2019 Jul;48(4):285-299. doi: 10.1080/16506073.2018.1533577. Epub 2018 Oct 29.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2015
Primary Completion (Actual)
June 1, 2016
Study Completion (Actual)
June 1, 2017
Study Registration Dates
First Submitted
March 30, 2015
First Submitted That Met QC Criteria
May 16, 2015
First Posted (Estimate)
May 20, 2015
Study Record Updates
Last Update Posted (Actual)
September 20, 2017
Last Update Submitted That Met QC Criteria
September 19, 2017
Last Verified
September 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- E-compared
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Major Depressive Disorders
-
Gang WangWest China Hospital; The First Hospital of Hebei Medical University; Tianjin... and other collaboratorsRecruitingMajor Depressive Disorder (MDD) | Depression - Major Depressive DisorderChina
-
Brian MickeyNational Institute of Mental Health (NIMH)RecruitingMajor Depressive Episode | Depression - Major Depressive Disorder | Treatment-Resistant Major Depressive DisorderUnited States
-
University Hospital, MontpellierCompletedMajor Depressive Disorders
-
Shanghai Mental Health CenterUnknownMajor Depressive Disorders
-
Zhifen LiuRecruiting
-
Shalvata Mental Health CenterUnknownMAjor Depressive DisorderIsrael
-
Assistance Publique - Hôpitaux de ParisUnknown
-
York UniversityCentre for Addiction and Mental HealthSuspendedDisorder, Major DepressiveCanada
-
Stanford UniversityNational Institute of Mental Health (NIMH)Recruiting
-
TakedaRecruitingMajor Depressive DisorderJapan
Clinical Trials on Cognitive behavioral therapy
-
Aleksandra StojanovicRecruitingAnxiety Disorders | Depression - Major Depressive DisorderSerbia
-
Eleos HealthMissouri Department of Mental HealthCompletedMood Disorders | Anxiety DisordersUnited States
-
Regionsenter for barn og unges psykiske helseThe Research Council of NorwayCompletedGeneralized Anxiety Disorder | Social Phobia | Separation Anxiety DisorderNorway
-
Claremont McKenna CollegeUniversity of California, Los AngelesCompleted
-
Vanderbilt UniversityNational Institute of Mental Health (NIMH)RecruitingDepressionUnited States
-
University of RochesterNational Institute of Nursing Research (NINR)CompletedDepression | Sleep | Stress Disorders, Post-TraumaticUnited States
-
University of South FloridaObsessive Compulsive FoundationCompletedObsessive Compulsive Disorder | Stepped Care Cognitive Behavioral TherapyUnited States
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Completed
-
University of PittsburghWithdrawnPsychosis | Prodromal Symptoms | Prodromal Stage | Prodromal StatesUnited States
-
Duke UniversityCompleted